EVERSPIN TECHNOLOGIES INC (MRAM) Stock Fundamental Analysis

NASDAQ:MRAM • US30041T1043

10.99 USD
-0.08 (-0.72%)
At close: Feb 20, 2026
10.75 USD
-0.24 (-2.18%)
After Hours: 2/20/2026, 8:00:01 PM
Fundamental Rating

4

Overall MRAM gets a fundamental rating of 4 out of 10. We evaluated MRAM against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. MRAM has a great financial health rating, but its profitability evaluates not so good. MRAM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year MRAM was profitable.
  • In the past year MRAM had a positive cash flow from operations.
  • MRAM had positive earnings in 4 of the past 5 years.
  • MRAM had a positive operating cash flow in 4 of the past 5 years.
MRAM Yearly Net Income VS EBIT VS OCF VS FCFMRAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • With a Return On Assets value of -0.71%, MRAM perfoms like the industry average, outperforming 43.36% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -0.86%, MRAM is in line with its industry, outperforming 43.36% of the companies in the same industry.
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROIC N/A
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
MRAM Yearly ROA, ROE, ROICMRAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • In the last couple of years the Profit Margin of MRAM has declined.
  • MRAM's Gross Margin of 51.31% is fine compared to the rest of the industry. MRAM outperforms 65.49% of its industry peers.
  • In the last couple of years the Gross Margin of MRAM has remained more or less at the same level.
  • MRAM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
MRAM Yearly Profit, Operating, Gross MarginsMRAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

8

2. Health

2.1 Basic Checks

  • MRAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MRAM has more shares outstanding
  • MRAM has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MRAM Yearly Shares OutstandingMRAM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MRAM Yearly Total Debt VS Total AssetsMRAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • MRAM has an Altman-Z score of 9.30. This indicates that MRAM is financially healthy and has little risk of bankruptcy at the moment.
  • MRAM has a better Altman-Z score (9.30) than 69.91% of its industry peers.
  • There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.3
ROIC/WACCN/A
WACC10.8%
MRAM Yearly LT Debt VS Equity VS FCFMRAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 5.84 indicates that MRAM has no problem at all paying its short term obligations.
  • MRAM's Current ratio of 5.84 is fine compared to the rest of the industry. MRAM outperforms 79.65% of its industry peers.
  • MRAM has a Quick Ratio of 4.81. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of MRAM (4.81) is better than 76.11% of its industry peers.
Industry RankSector Rank
Current Ratio 5.84
Quick Ratio 4.81
MRAM Yearly Current Assets VS Current LiabilitesMRAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

  • The earnings per share for MRAM have decreased strongly by -35.14% in the last year.
  • The Earnings Per Share has been decreasing by -4.88% on average over the past years.
  • The Revenue has decreased by -0.41% in the past year.
  • Measured over the past years, MRAM shows a small growth in Revenue. The Revenue has been growing by 6.09% on average per year.
EPS 1Y (TTM)-35.14%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-64.71%
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%16.27%

3.2 Future

  • MRAM is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.57% yearly.
  • The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.
EPS Next Y-29.82%
EPS Next 2Y-2.78%
EPS Next 3Y-8.57%
EPS Next 5YN/A
Revenue Next Year10.47%
Revenue Next 2Y9.93%
Revenue Next 3Y9.4%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MRAM Yearly Revenue VS EstimatesMRAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
MRAM Yearly EPS VS EstimatesMRAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 47.78, MRAM can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, MRAM is valued a bit cheaper than 66.37% of the companies in the same industry.
  • MRAM is valuated expensively when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 35.56, which means the current valuation is very expensive for MRAM.
  • MRAM's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. MRAM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 47.78
Fwd PE 35.56
MRAM Price Earnings VS Forward Price EarningsMRAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MRAM is valued a bit cheaper than the industry average as 68.14% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 53.7
EV/EBITDA N/A
MRAM Per share dataMRAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as MRAM's earnings are expected to decrease with -8.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.78%
EPS Next 3Y-8.57%

0

5. Dividend

5.1 Amount

  • MRAM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EVERSPIN TECHNOLOGIES INC

NASDAQ:MRAM (2/20/2026, 8:00:01 PM)

After market: 10.75 -0.24 (-2.18%)

10.99

-0.08 (-0.72%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners59.74%
Inst Owner Change9.68%
Ins Owners5.05%
Ins Owner Change-2.02%
Market Cap251.23M
Revenue(TTM)53.64M
Net Income(TTM)-568.00K
Analysts82.5
Price Target13.01 (18.38%)
Short Float %2.97%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.18%
Min EPS beat(2)17.65%
Max EPS beat(2)30.72%
EPS beat(4)4
Avg EPS beat(4)336.68%
Min EPS beat(4)17.65%
Max EPS beat(4)1207.19%
EPS beat(8)8
Avg EPS beat(8)401.03%
EPS beat(12)12
Avg EPS beat(12)293.44%
EPS beat(16)16
Avg EPS beat(16)625.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-0.44%
Revenue beat(4)2
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)3.87%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)8
Avg Revenue beat(12)1.3%
Revenue beat(16)12
Avg Revenue beat(16)1.75%
PT rev (1m)21.43%
PT rev (3m)50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.55%
EPS NY rev (1m)0%
EPS NY rev (3m)7.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 47.78
Fwd PE 35.56
P/S 4.68
P/FCF 53.7
P/OCF 22.49
P/B 3.82
P/tB 3.95
EV/EBITDA N/A
EPS(TTM)0.23
EY2.09%
EPS(NY)0.31
Fwd EY2.81%
FCF(TTM)0.2
FCFY1.86%
OCF(TTM)0.49
OCFY4.45%
SpS2.35
BVpS2.88
TBVpS2.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.86
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -0.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.31%
FCFM 8.72%
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
F-Score3
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 209.73%
Cap/Sales 12.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.84
Quick Ratio 4.81
Altman-Z 9.3
F-Score3
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)192.66%
Cap/Depr(5y)132.94%
Cap/Sales(3y)4.31%
Cap/Sales(5y)3.11%
Profit Quality(3y)251.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.14%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-64.71%
EPS Next Y-29.82%
EPS Next 2Y-2.78%
EPS Next 3Y-8.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.41%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%16.27%
Revenue Next Year10.47%
Revenue Next 2Y9.93%
Revenue Next 3Y9.4%
Revenue Next 5YN/A
EBIT growth 1Y-77.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1162.5%
EBIT Next 3Y181.26%
EBIT Next 5YN/A
FCF growth 1Y-66.03%
FCF growth 3Y-21.44%
FCF growth 5YN/A
OCF growth 1Y-31.56%
OCF growth 3Y-8.8%
OCF growth 5YN/A

EVERSPIN TECHNOLOGIES INC / MRAM FAQ

Can you provide the ChartMill fundamental rating for EVERSPIN TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 4 / 10 to MRAM.


What is the valuation status for MRAM stock?

ChartMill assigns a valuation rating of 2 / 10 to EVERSPIN TECHNOLOGIES INC (MRAM). This can be considered as Overvalued.


Can you provide the profitability details for EVERSPIN TECHNOLOGIES INC?

EVERSPIN TECHNOLOGIES INC (MRAM) has a profitability rating of 3 / 10.


Can you provide the financial health for MRAM stock?

The financial health rating of EVERSPIN TECHNOLOGIES INC (MRAM) is 8 / 10.